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Abstract
Extra-cellular adenosine is an important regulator of inflammatory responses. It is generated from released ATP by a cascade
of ectoenzymes and degraded by adenosine deaminase (ADA). There are two types of enzymes with ADA activity: ADA1 and
ADGF/ADA2. ADA2 activity originates from macrophages and dendritic cells and is associated with inflammatory responses
in humans and rats. Drosophila possesses a family of six ADGF proteins with ADGF-A being the main regulator of extra-
cellular adenosine during larval stages. Herein we present the generation of a GFP reporter for ADGF-A expression by a
precise replacement of the ADGF-A coding sequence with GFP using homologous recombination. We show that the
reporter is specifically expressed in aggregating hemocytes (Drosophila immune cells) forming melanotic capsules; a
characteristic of inflammatory response. Our vital reporter thus confirms ADA expression in sites of inflammation in vivo and
demonstrates that the requirement for ADA activity during inflammatory response is evolutionary conserved from insects to
vertebrates. Our results also suggest that ADA activity is achieved specifically within sites of inflammation by an
uncharacterized post-transcriptional regulation based mechanism. Utilizing various mutants that induce melanotic capsule
formation and also a real immune challenge provided by parasitic wasps, we show that the acute expression of the ADGF-A
protein is not driven by one specific signaling cascade but is rather associated with the behavior of immune cells during the
general inflammatory response. Connecting the exclusive expression of ADGF-A within sites of inflammation, as presented
here, with the release of energy stores when the ADGF-A activity is absent, suggests that extra-cellular adenosine may
function as a signal for energy allocation during immune response and that ADGF-A/ADA2 expression in such sites of
inflammation may regulate this role.
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Introduction
Extra-cellular adenosine is an important regulatory molecule
with a low physiological concentration that can rapidly increase
during tissue damage, inflammation, ischemia or hypoxia. In
damaged tissues and inflammatory responses, extra-cellular
adenosine is a product of ATP degradation, mediated by a
cascade of ectoenzymes. Both ATP and adenosine stimulate
purinergic receptors, and their release, signaling and progressive
decrease regulate the onset of the acute inflammatory response,
the fine-tuning of ongoing inflammation and its eventual down-
regulation [1]. However the overall regulation of inflammatory
responses by ATP and adenosine is quite complex, especially in
mammalian adaptive immunity, and thus many questions
regarding the roles of ATP and adenosine persist.
An important step in this regulation is the degradation of
adenosine by adenosine deaminase (ADA), an enzyme that
converts adenosine and deoxyadenosine to inosine and deoxyino-
sine, respectively. Generally, two types of enzymes with the ADA
activity are known; the ADA1 family proteins and adenosine
deaminase-related growth factors (ADGF) or ADA2-like proteins.
ADA1 is present both in prokaryotes and eukaryotes and has been
studied for long time, mainly because its deficiency in humans
causes severe combined immunodeficiency (SCID) syndrome.
Although the most studied function of ADA1 is the reduction of
toxic intracellular levels of adenosine, especially for lymphocytes
[2], ADA1 has also been detected as an ectoenzyme associated
with cell surface receptors [3].
Although ADA2 activity in human plasma was discovered long
time ago [4], the protein responsible for this activity was only
recently isolated [5]. ADA2 (ENSG00000093072) is a secreted
protein and adenosine seems to be its only substrate [6]. ADA2
activity is significantly increased in the pleural effusions of
tuberculosis patients [7] and the serum of patients infected with
HIV [8]. It was also shown that macrophages are the source of
ADA2 activity during inflammatory responses in rats [9]. Zavialov
et al. [10] showed that ADA2 protein secreted by monocytes
undergoing differentiation is the only source of ADA activity from
these cells. They further revealed that human ADA2 promotes
CD4
+ T cell-dependent differentiation of monocytes to macro-
phages and their subsequent proliferation and that this role of
ADA2 is independent of its ADA catalytic function.
ADA2 belongs to the family of ADGF proteins, first
characterized in insect [11]. The ADGF-A protein (FBgn0036752)
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and both proteins share all structure domains, including those
considered unique to ADA2 [13]. However, ADGF-A, as with
other ADGFs from lower species, has a higher affinity for
adenosine (similar to ADA1) than human ADA2. According to
Zavialov et al. [13], human ADA2 may have become specialized
during evolution to be an adenosine deaminase specifically active
in sites of high adenosine concentration and lower pH, typified by
sites of inflammation.
We have showed that ADGF-A mRNA is expressed in the
Drosophila hematopoietic organ, called the lymph gland [12] and
that this expression is required for larval survival [14]. Drosophila
hematopoiesis and cellular immunity are much simpler than in
vertebrates, nevertheless both systems share many features [15].
The main component of cellular immunity in flies is represented
by plasmatocytes that are macrophage-like cells with phagocytic
activity. These cells are responsible for the inflammatory response
to tissue damage (clearance of tissue debris and healing) and
infection. In similarity to vertebrate systems, these macrophage-
like cells are attracted to sites of injury where they adhere and
become phagocytic [16]. This ability to recognize and adhere to
damaged or ‘‘nonself’’ tissue is an ancestral feature of blood cells.
In the case of larger objects, such as parasitic wasp eggs,
specialized cells called lamellocytes (large flat cells) differentiate
from prohemocytes and encapsulate the foreign object, thus
isolating it from the rest of the body cavity. The intruding object is
then destroyed by melanization; an important immune mechanism
in arthropods utilizing toxic quinone substances and other short-
lived reaction intermediates [17]. These substances are also
involved in the formation of more long-lasting products such as
the melanin that physically encapsulates pathogens. Furthermore,
reaction intermediates in the melanin pathway participate in the
wound healing process by the formation of covalent links in
damaged tissues and results in sclerotization.
Since hemocyte ADGF-A mRNA expression is required for
larval survival, we were interested in the regulation of its
expression. However, because there is no available antibody
against ADGF-A, we decided to produce a vital GFP reporter for
its expression using homologous recombination. Here we show
that this reporter is expressed in vivo, in aggregating larval
hemocytes at sites of inflammation and that the acute expression of
the ADGF-A protein is most probably regulated at post-
transcriptional level.
Materials and Methods
Drosophila strains and culture
The AGFP reporter was produced as described in File S1. The
line depicted as AGFP[23], was used for the experiments presented
herein; this line was kept as w; AGFP[23]/TM6B and w;
AGFP[23]/TM3 Act.GFP Ser and crossed to the wild-type Oregon
R strain to obtain AGFP[23]/+. Additional lines used in this work
were as following: Oregon-R as wild-type strain, w; adgf-a
karel/TM6B,
w; cactus[E8]/CyOGFP; AGFP[23]/TM6B, w; cactus[IIIG]/CyOGFP,
w; cactus[D13]/CyOGFP and y[1] v[1] hop[Tum]/FM7c. All flies
were raised on corn meal/sucrose/agar medium and kept at 25uC.
Wasp parazitation
w; AGFP[23]/TM6B flies crossed to Oregon-R flies and only
Oregon-R flies were left to lay eggs for 12 hours in regular food-
containing vials. The second-instar larvae were then immunized
by a parasitic wasp Leptopilina boulardi for two hours. The wasps
were then discarded and the infected larvae permitted to continue
their development for another 24–48 hours at 25uC. GFP
fluorescence was then analyzed in encapsulated wasp eggs
dissected from the third-instar larvae, as described below.
GFP fluorescence analysis
GFP fluorescence was analyzed in dechorionated embryos,
whole and dissected larvae and pupae and in adult flies using
fluorescent either stereomicroscopy and inverted microscopy.
Hemocytes, melanotic capsules and parasitic wasp eggs were
obtained by careful dissection of third-instar larvae in a drop of
Ringer solution on a microscopic slide and immediately examined
by one of fluorescent microscopic techniques. Samples were
analyzed using differential interference contrast (DIC) and the
Olympus U-MWG2 GFP filter settings. Micrographs were
obtained using a color CCD, Olympus DP70 camera.
Expression analysis by RT-PCR and Real-time PCR
Total RNA was isolated using TRI Reagent (Molecular
Research Center, Cincinnati, Ohio) according to manufacturer’s
instructions. RNA was isolated from w; AGFP[23]/TM3 Act.GFP
Ser stock in the following hours after egg laying: 14–18 h
(embryos), 34–38 h (first-instar larvae), 58–62 h (second-instar
larvae), 82–86 h (third-instar larvae) and from the third-instar
wandering larvae, white prepupae, pupae 26–34 h after pupation
and three days-old adult males and females. cDNA was generated
from 2.4 mg of RNA treated with TURBO DNase I (Ambion,
Austin, TX) using the SuperScript III Reverse Transcriptase kit
(Invitrogen, Carlsbad, CA) with oligo(dT) primering. Actin
amplification was used to determine the final dilution of cDNA
from each sample for the PCR reactions which were performed
using the following primers: 59-TACCCCATTGAGCACGG-
TAT-39 and 59-GGTCATCTTCTCACGGTTGG-39 for Actin,
59-AATCGGAGCTCCTCAATCGC-39 and 59-GCTACACA-
TTGATCCTAGC-39 for AGFP,5 9-AGGTTCTCATCCA-
CAGTGG-39 and 59-CGGACTACTACTACAAAGC-39 for AD-
GF-A.
Third-instar wandering larvae of the following genotypes were
used for Real-time PCR analysis: AGFP[23]/+, AGFP[23]/
AGFP[23], cactus[IIIG]/cactus[E8]; AGFP[23]/+, cactus[D13]/cac-
tus[E8]; AGFP[23]/+. Total RNA was isolated (1) from 60 whole
larvae using TRI Reagent and (2) from hemocytes as follows: 15–
30 larvae were dissected one at a time in Ringer solution in 1.5-ml
tubes and the hemolymph collected (the remaining body was
discarded). The hemolymph were then centrifuged for 5 min at
15006g, the supernatant discarded and total RNA isolated from
the collected hemocytes using the RNAqueous-Micro kit (Ambion,
Austin, TX). The RNA was then treated with TURBO DNase I.
The concentration of RNA was determined by NanoDrop
ND1000 (Thermo Fisher Scientific Inc., Waltham, MA) analysis
and cDNA synthesized using the SuperScript III Reverse
Transcriptase kit with oligo(dT) primering. The cDNA was then
treated with RNaseH (Takara, Japan). Samples were analyzed by
Real-time PCR using 16 Syber green Supermix (Biorad,
Hercules, CA) and 5 pmol of each primer in CFX96 Real Time
System C1000 (Biorad) as triplicate measurements. The following
primers were used: 59-CTTCATCCGCCACCAGTC-39 and 59-
CACGTTGTGCACCAGGAA-39 for Rp49,5 9-GGATCCCC-
CAGTCAACGG-39 specific for ADGF-A,5 9-TGCTTCTGC-
TAGGATCAATGTGTA-39 specific for AGFP and 59-CTGA-
GTGGATGCGAATGAGAGTG-39 common for ADGF and
AGFP. Biorad CFX Manager software was used to quantify
transcript levels by comparison to relative standard curves
generated for each gene by serial (56) dilutions of Drosophila
genomic DNA. Levels of ADGF-A and AGFP were normalized with
Rp49 levels from the same cDNA samples and plotted as ADGF-A
ADA in Drosophila Inflammation
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mean 6 SEM of three independent experiments. The experimen-
tal significance was determined using a Student’s t test utilizing the
STATISTICA 6 software (StatSoft) package.
Results
Generation of the ADGF-A reporter system
We used homologous recombination to produce a GFP reporter
for the analysis of endogenous, in vivo, levels of ADGF-A
expression by the precise replacement of the ADGF-A coding
sequence with that of GFP (Figure 1). This therefore ensured that
all the surrounding regulatory sequences, including 59 and 39
untranslated regions, of ADGF-A locus remained intact. We
utilized a destabilized version of the Green Fluorescent Protein
(dGFP) [18], that makes it possible to analyze dynamic changes in
ADGF-A expression since the dGFP does not accumulate in cells as
it is turned-over in around 2–4 hours.
We used the ‘ends-in’ version of homologous recombination
[19] that permitted precise exchange of the coding sequences in
two steps and without leaving any traces of the recombination
process. The first recombination step produced a duplication in
the ADGF-A containing region, with the ADGF-A coding sequence
at one side and the dGFP coding sequence on the other side (File
S1). The second recombination step resulted in a reduction (File
S1) of this configuration, thus producing the sequence assembly
as shown in Figure 1. Details of the whole procedure are
described in File S1.
We obtained a total 12 lines exhibiting the correct replacement
as judged by the successful hybridization of the dGFP probe to
DNA fragments of correct size in Southern blotting analysis
(Figure 2). We named this replacement as AGFP (for ADGF-A GFP
reporter). The Southern blot results were further confirmed by
PCR and sequencing (data not shown). In two lines (8-4 and 74-3;
Figure 2), the second recombination event occurred downstream
of the ADGF-A/dGFP sequences restoring a wild-type gene
arrangement (File S1). This was confirmed by PCR analysis
resulting in an amplification of the ADGF-A fragment size instead
of the shorter dGFP sequence (data not shown).
Since the replacement of the ADGF-A coding sequence results in
a null mutation of this gene we examined the homozygous AGFP
or heterozygous adgf-a/AGFP larvae and found that they exhibited
the same phenotype as the originally described adgf-a mutant [14]
(see further); thus providing confirmation at the phenotypic level
that the replacement successfully occurred within the ADGF-A
locus.
Expression of AGFP mRNA
Our molecular characterization (Figure 2 and File S1)
confirmed that the coding sequence of the ADGF-A gene had
been accurately replaced by the coding sequence of dGFP.
Therefore, we further analyzed if the expression of AGFP reporter
mRNA corresponded to the endogenous ADGF-A expression.
ADGF-A mRNA is normally expressed throughout all stages of
development [12] (Figure 3) and similarly, the AGFP mRNA was
also expressed at all stages (Figure 3). This demonstrated that our
AGFP reporter expression system was able to faithfully report the
temporal expression of the endogenous ADGF-A gene.
Moreover Figure 4A demonstrates that the overall levels of
mRNA are similar (p=0,286) for both ADGF-A and AGFP
transcripts when measured in samples obtained from the
AGFP[23]/+ heterozygous wandering larvae; where ADGF-A is
expressed from wild-type chromosome and AGFP from the
modified one.
We had previously shown that the expression of ADGF-A in the
larval hematopoietic system is crucial for larval survival [14]. In
agreement with this observation, Figure 4C demonstrates that the
expression of ADGF-A in larval hemocytes is ,10 times stronger
compared to overall larval expression. This cell type-specific
expression pattern is also represented in the expression of the
AGFP reporter (Figure 4B, p=0,344), further confirming the
fidelity of the created reporter system in relaying the normal
pattern of endogenous ADGF-A expression.
Figure 1. Schematic diagram of the ADGF-A coding sequence replacement by the coding sequence of a reporter gene encoding the
destabilized GFP. The arrangement of three ADGF genes on the wild-type chromosome III is shown on the top. The bottom panel shows gene
organization in the reporter system. Coding sequences are depicted by dark boxes and white boxes indicate 59 and 39 untranslated regions of the
genes. Introns are represented by chevron-shaped lines, intergenic spaces by horizontal lines. Dashed lines depict the replacement. 59-39 orientation
of all three genes is shown from left to right. The ADGF-A gene shares the first exon with the ADGF-A2 gene but it also uses an alternative
transcription start site, specific only for the ADGF-A gene marked by an arrow. XhoI restriction sites in the sequence are depicted by triangles and the
fragment lengths after the digestion are shown above each sequence in kilobases.
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Utilizing our AGFP reporter we analyzed the in vivo ADGF-A
expression by observing the fluorescence of dGFP in the AGFP/+
animals at all developmental stages. Surprisingly, we did not
detect any fluorescence above background levels in any tissue/
cells (data not shown), including larval hemocytes where we
could detect mRNA in relatively high quantities. We examined
several independent versions of our reporter line, including
AGFP[23] and AGFP[72], that were analyzed thoroughly (data
not shown).
We also tried to detect the dGFP protein in fixed AGFP/+
embryos and larvae by immuno-fluorescence using an anti-GFP
antibody. We hoped this would overcome both the background
autofluorescence that is close to the green spectrum (by using
secondary antibody conjugated to the red flourophore, Cy3) and
potentially low levels of dGFP protein present by signal
amplification achievable using a polyclonal antibody. We also
tried to detect the dGFP protein in whole larval and hemocyte
lysates by western blotting. However, we were unable to detect
the dGFP protein by any of these methods (data not shown),
suggesting that there is either no expression of the AGFP
reporter or that expression levels fall below our detection
thresholds.
Interestingly, we did detect GFP fluorescence in aggregating
hemocytes of AGFP homozygous animals (Figure 5B,D,F). AGFP
homozygotes are effectively adgf-a gene mutants and thus present
the same mutant phenotype that includes melanotic capsule
formation associated with differentiating hemocytes [14]. The
strongest GFP expression was detected in the melanotic capsules
(Figure 5F). These capsules are formed by aggregating plasma-
tocytes and lamellocytes, with inside melanization. While most of
the circulating, i.e. non-adhered plasmatocytes and lamellocytes
did not express GFP (Figure 5C), the aggregating cells did
(Figure 5B). This was especially apparent in large aggregates
(Figure 5D) that eventually formed melanized capsules
(Figure 5F).
It was possible that this observed fluorescence was due to an
increased expression of AGFP mRNA in adgf-a deficient, AGFP
homozygous larvae. Therefore we measured AGFP mRNA levels
in AGFP homozygous and heterozygous larvae and hemocytes. We
did not detect any significant differences in mRNA levels
(P=0,286 for larvae and p=0,45 for hemocytes, respectively)
between homozygotes and heterozygotes (heterozygotes levels
were doubled due to a presence of only one AGFP allele)
(Figure 6A,B). It is important to note that there was quite high
variability in the mRNA levels of homozygotes most likely
attributable to variability in the mutant phenotype. This is
because development was quite delayed making it difficult to
collect larvae at precisely the same stage. More valuable results for
comparison were obtained using cactus mutants (see below).
Figure 2. Southern blot analysis of the second recombination step. Genomic DNA was digested with XhoI restriction enzyme and the
membrane was hybridized with the dGFP probe. The size of the XhoI fragment hybridised with the dGFP probe, after the successful replacement is
7.7 kb (Figure 1 and File S1) - the DXI line with duplication was used as a control for the fragment size (File S1). Sizes in kilobases are depicted above
each band of the DIG-labeled marker.
doi:10.1371/journal.pone.0017741.g002
Figure 3. Developmental profile of ADGF-A and AGFP mRNA
expression by RT-PCR. The total RNA was isolated from w; AGFP[23]/
TM3 Act.GFP Ser individuals at the following stages: embryos (E), first-
instar larval stage (L1), second-instar larval stage (L2), third-instar larval
stage (L3), wandering larvae (W), prepupae (PP), pupae (P), male adults
(M) and female adults (F). RNA was reverse transcribed and amplified by
PCR using ADGF-A or AGFP specific primers. Actin cDNA was amplified
as template control.
doi:10.1371/journal.pone.0017741.g003
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PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e17741AGFP expression in cactus mutants
The melanotic capsule phenotype of the adgf-a mutant is similar
to another phenotype caused by the constitutive activation of Toll
signaling [20]. This can be achieved by a zygotic mutation in the
Cactus gene (FBgn0000250), an inhibitor of the Rel transcription
factors Dorsal and Dif, that activate Toll target genes. Therefore we
tested if cactus mutations would lead to the expression of our AGFP
reporter.
Similarly to AGFP homozygous larvae, both hypomorphic
(cactus[E8]/cactus[IIIG]) and null (cactus[E8]/cactus[D13]) mutant
combinations [20] together with AGFP[23]/+ showed GFP
fluorescence in aggregating hemocytes and especially in the outer
border of melanotic capsules (data not shown and Figure 5G).
Since this result was obtained in AGFP[23]/+ heterozygotes, it
demonstrated that it was not the adgf-a mutant phenotype, nor the
presence of two AGFP copies that are required for AGFP reporter
expression. Rather it was the behavior of hemocytes and
particularly their aggregation that causes the expression of dGFP
protein.
We also assayed the AGFP mRNA levels in the cactus mutant
background. We did not detect significant changes in AGFP
mRNA expression when comparing hemocytes with and without
cactus mutations (Figure 6A). When the AGFP levels were
compared in whole larvae, the amount was however increased
in the cactus mutants (Figure 6B). Since we did not observe GFP
expression in any other cells/tissues of the cactus mutants, besides
the hemocytes, this difference was most likely caused by the
increased number of hemocytes per larva in the cactus mutants
[20].
AGFP expression in hop
Tum mutant
The hop
Tum mutation (FBal0005547) results in the hyperactivity
of the Jak kinase Hopscotch [21], leading to the aggregation of
hemocytes and the formation of melanotic capsules. In similarity
to AGFP homozygotes and cactus mutants, hop
Tum mutants also
promote the expression of the AGFP reporter in hemocyte
aggregates that were forming melanotic capsules (Figure 5H).
AGFP expression in larvae infected by parasitic wasps
As we know that the AGFP reporter was expressed in larvae
harboring different mutations that induced melanotic capsule
formation, we used a parasitic wasp Leptopilina boulardi to test its
expression during a real immune challenge that would result in
melanotic capsule formation. When the parasitic wasps lay their
eggs in Drosophila larvae, the plasmatocytes attach themselves to
the surface of the egg and thereafter the egg is encapsulated by
lamellocytes and destroyed by melanization [22]. We found that
the AGFP reporter started to produce a dGFP signal during the
encapsulation process (Figure 7B) and it was strongly expressed in
fully encapsulated and melanized eggs (Figure 7C). This result
revealed that our AGFP reporter system was able to inform us as
to the in vivo expression of ADGF-A status in response to a bona
fide immune challenge within a living animal.
Discussion
Generation and verification of reporter
The adenosine deaminase activity of ADGF-A is an important
regulator of extra-cellular adenosine in Drosophila larvae [14].
Therefore we decided to make a vital GFP reporter system which
would allow us to observe dynamic changes in the ADGF-A
expression in vivo.
This work demonstrated that it was possible to use the ‘ends-in’
based method of homologous recombination [23] to specifically
and precisely replace a target gene sequence with that of a reporter
(or other heterologous sequence). We used this approach to
precisely exchange the entire coding-sequence of the ADGF-A gene
with that of the dGFP reporter, leaving intact all the regulatory
Figure 4. Real-time PCR analysis of the ADGF-A and AGFP expression in the AGFP[23]/+ larvae. (A) Expression level in whole larvae and (B)
circulating hemocytes. (C) Combined expression in whole larvae and in hemocytes plotted on one graph to demonstrate the difference in levels. Data
represent mean values 6 SEM, normalized relative to the endogenous control.
doi:10.1371/journal.pone.0017741.g004
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allowed us to faithfully reproduce the natural expression pattern of
ADGF-A in a manner offering maximal fidelity, especially when
compared with more conventional methods of transgenic reporter
fly generation that rely on random sites of genomic integration.
Our molecular and phenotypic characterizations of recombi-
nation events, coupled with the developmental and the hemocyte-
specific expression profiling clearly demonstrated the successful
creation of the reporter. Furthermore that it faithfully recapitulates
the expression pattern of the endogenous ADGF-A. Although
newer, and arguably less laborious, strategies to target genes [24]
or to tag proteins utilizing novel recombineering strategies [25] are
now becoming available, it is important to note that our reporter
does represents the first faithful reporter of ADGF-A expression to
be published. We anticipate that this will be of use to the wider
Drosophila community, especially in light of the absence of anti-
ADGF-A antiserum.
Although reporter-derived AGFP mRNA was present in all
developmental stages (and in similar levels to the endogenous
ADGF-A transcripts), we did not detect any GFP protein
expression at any developmental stage under normal growth
conditions. This may be because the expression levels were too low
to be detectable using the available methodology. Additionally in
the case of heterozygous animals, the reporter was only expressed
from one of the two alleles, thus lowering the potentially detectable
expression to ,50% compared to normal endogenous ADGF-A
expression. However, the detectable GFP fluorescence only at the
sites of hemocyte aggregation in both AGFP homozygous and
heterozygous animals suggests that heterozygosity of the reporter
was not the reason. We also used a destabilized version of GFP
that is reported to undergo degradation within a couple hours
[18]. Whilst this allowed us to observe the important dynamic
changes in ADGF-A expression, it probably also lowered the
overall reporter signal and as a consequence its sensitivity,
Figure 5. AGFP expression in hemocytes and melanotic capsules obtained from the late third-instar larvae. (A) Aggregating
lamellocytes from the adgf-a mutant larvae without AGFP as a control to account for autofluorescence. (B) Aggregating lamellocytes from AGFP[23]
homozygotes showing GFP fluorescence. (C) Non-aggregating plasmatocytes and lamellocytes from AGFP[23] homozygotes that rarely displayed any
GFP fluorescence. (D) A clump of plasmatocytes and lamellocytes from AGFP[23] homozygotes exhibiting strong GFP expression. (E) A melanotic
capsule from the adgf-a mutant showing only yellowish autofluorescence of the melanized region. (F) GFP fluorescence in hemocytes surrounding a
melanotic capsule from AGFP[23] homozygotes. (G) A melanotic capsule from the null cactus mutant with AGFP reporter (cactus[E8]/cactus[D13];
AGFP[23]/+) showing GFP expression in surface lamellocytes. (H) A melanizing clump with lamellocytes and plasmatocytes expressing GFP in hop
Tum;
AGFP[23]/+ mutant. Scale bar (50 mm) is shown in white on DIC images. Genotypes are shown on corresponding fluorescent micrographs
distinguished with an apostrophe. All fluorescent images were captured using the same exposure settings.
doi:10.1371/journal.pone.0017741.g005
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Therefore we can not conclude that there is no expression of
ADGF-A/AGFP at the protein level under normal growth
conditions but rather if there is any expression, it is certainly very
low.
Expression of reporter in site of inflammation
In agreement with the previously reported expression of ADGF-
A mRNA in the hematopoietic organ [12], we found that the
ADGF-A/AGFP mRNA was quite abundant in hemocytes under
normal physiological conditions; typified by circulating and sessile
non-activated macrophage-like cells called plasmatocytes. Never-
theless, we rarely observed GFP fluorescence in these cells.
However we found that GFP expression was induced in hemocytes
during the formation of melanotic capsules, a type of immune
response typical of insects [17]. The purpose of melanization is to
either isolate and destroy larger foreign bodies that are too big to
be phagocytosed or its involvement in the healing of larger
wounds. Melanotic capsule formation can be considered a form of
inflammatory response since it involves the recruitment and
adherence of immune cells (including the macrophage-like
plasmatocytes and specialized insect cells called lamellocytes) to
large invading objects, as required. Furthermore, both plasmato-
cytes and lamellocytes expressed the AGFP reporter as they
became adhesive and especially in the site of melanotic capsule
formation, i.e. the site of inflammation.
We used four different ways to induce melanotic capsule
formation in larvae. Firstly, in the adgf-a mutant, it was induced by
a disintegration of endogenous larval tissue, the fat body [14,26].
Secondly, in the cactus mutant, it was induced by constitutive
activation of Toll signaling leading to lamellocytes differentiation
and the spontaneous aggregation of both plasmatocytes and
lamellocytes with consequent melanotic capsule formation [20].
Thirdly, in the hop
Tum mutant, hyperactivation of the JAK/STAT
signalling cascade led to melanotic capsule formation [21]. Lastly,
melanotic capsule formation was induced by a genuine immune
reaction to an egg deposited by a parasitic species of wasp. This
last approach demonstrated that the observed AGFP reporter
expression did not occur as a consequence of the genetic
manipulations used in the other three cases, but rather was
indicative of a bona fide, in vivo immune response. In all four cases
the AGFP reporter was only expressed in the adherent hemocytes
of the melanotic capsule, thus indicating that the ADGF-A protein
expression is tightly associated with hemocyte function during the
immune reaction regardless of the inducing factor and signaling
cascades involved.
Is ADGF-A expression post-transcriptionally regulated?
We did not detect any significant increases in AGFP mRNA
levels in hemocytes isolated from larvae forming melanotic
capsules (and expressing abundantly detectable GFP fluorescence),
when compared to hemocytes from AGFP/+ larvae with no
melanotic capsules (and exhibiting a lack of GFP fluorescence). In
addition, the ADGF-A/AGFP mRNA was quite abundant in these
unchallenged wild-type hemocytes, corresponding to ,10% of the
mRNA levels of the ribosomal house-keeping protein gene, Rp49.
Figure 6. Real-time PCR analysis of AGFP mRNA expression. (A) Expression in hemocytes and (B) in wandering larvae. Data represent the
mean values 6 SEM, normalized relative to the endogenous control. The following genotypes are shown: AGFP[23]/+, AGFP[23]/AGFP[23], cactus[D13]/
cactus[E8]; AGFP[23]/+ and cactus[IIIG]/cactus[E8]; AGFP[23]/+. Columns indicated by asterisks are significantly different from AGFP[23]/+ control
(hemocytes: p(AGFP/AGFP)=0,45; p(D13/E8)=0,27; p(IIIG/E8)=0,45; larvae: p(AGFP/AGFP)=0,2862; p(D13/E8)=0,00028; p(IIIG/E8)=0,0063).
doi:10.1371/journal.pone.0017741.g006
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regulative mechanism of ADGF-A/AGFP protein expression. It
should be stressed that both 59 and 39 UTRs of the ADGF-A
mRNA were preserved in the AGFP reporter mRNA; only the
coding sequence was replaced. Therefore, the potential for adgf-a
gene UTR-mediated post-transcriptional regulation of the GFP
reporter sequence exists. Since adenosine is readily transported
across the plasma membrane by nucleoside transporters [27], an
intriguing possibility may be provided by the potential for a
riboswitch mechanism, similar to that present in prokaryotic
adenosine deaminase based regulation [28]. Riboswitches have
mostly been described as mechanisms of bacterial regulation that
enable rapid responses to environmental stimuli. They typically act
via the binding of specific ligands (e.g. purine molecules) to
riboswitch regulatory elements in 59 UTR of mRNA’s, thus
prompting or inhibiting their translation. It is therefore possible
that when hemocytes find themselves in environments of high
concentrations of extra-cellular adenosine, they take the adenosine
up and it then binds to a riboswitch within the 59 UTR of the
ADGF-A mRNA, that subsequently activates the translation of the
ADGF-A protein. Accordingly, we did observe increases in the
expression of our AGFP reporter system, when isolated but non-
adhered hemocytes were challenged by a dose of exogenous
adenosine (data not shown). However we were unable to obtain
quantifiable data due to the inherently weak AGFP signal in our
system. Furthermore, it is also possible that the activation or
adherence of hemocytes also play a role in this regulation that we
are unable to yet model. Nevertheless, it will be very important to
further explore the mechanism of this post-transcriptional
regulation evidently at work in our system and investigate whether
a similar mechanism is also operating in mammalian systems.
What is the role of ADGF/ADA2 in the site of
inflammation?
There are at least two ways ADA2 can influence the inflammatory
response. Firstly, by its catalytic-independent signaling function and
secondly, via regulating adenosine levels through its adenosine
deaminase enzymatic activity. It is not known if Drosophila ADGF-A
exerts a signaling function similar to human ADA2. This function
might be an evolutionary adaptation in vertebrates since the signaling
function is associated with adaptive immunity [10] and includes cells
that are not present in the innate immunity of Drosophila.
Interestingly, insect wounds do not undergo the same burst of
cellular proliferation and differentiation that characterizes mamma-
lian wounds healing [29]. However, ADGF-A does shares all the
protein domains, including the putative receptor binding domain,
with human ADA2 [13] and thus the potential signaling role of
ADGF proteins in insects should to be addressed.
T h er o l eo fA D G F / A D A 2i nt h es i t eo fi n f l a m m a t i o ni sc e r t a i n l y
linked to its catalytic activity (the conversion of extra-cellular
Figure 7. Encapsulation of parasitic wasp egg. (A) Partially encapsulated wasp eggs from Oregon-R larva as a control displaying only yellow
auto-fluorescence of the wasp eggs. (B) Partially encapsulated wasp egg from AGFP[23]/+ larva showing a faint but clearly visible green fluorescence
of AGFP reporter in the encapsulating lamellocytes. (C) A fully encapsulated and melanized wasp egg from AGFP[23]/+ larva exhibitting strong AGFP
expression in the encapsulating material. DIC (top with 100-mm black scale bar) and corresponding fluorescence (bottom labeled by letter plus an
apostrophe) images are shown in each panel.
doi:10.1371/journal.pone.0017741.g007
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cellular adenosine during inflammatory response; to mitigate the
severity of the potentially harmful response by its anti-inflammatory
role and to readjust the energy ‘supply-to-demand’ ratio by
stimulating additional blood flow and glucose release from stores.
Changes in the relative amounts of ATP and adenosine form
the core of inflammatory response regulation, and act through the
purinergic receptors [1]. The release of ATP into the extra-cellular
space acts a potently pro-inflammatory, ‘danger-associated
molecular pattern’ (DAMP) signal. Such inflammatory processes
are associated with a significant increase in the expression of ecto-
59nucleotidase that acts to rapidly convert ATP into adenosine
[30]. Furthermore, in vertebrates, adenosine itself is a strongly
anti-inflammatory molecule [1] and acts later to down-regulate
inflammation. Therefore during acute inflammation, increased
extra-cellular adenosine is rapidly metabolized to inosine by
adenosine deaminase. Indeed, a close correlation can be observed
between inflammation and local increases in adenosine deaminase
activity [7,9]. Our results in Drosophila confirm this correlation in
vivo and suggest that adenosine plays a similar role during the
inflammatory response of insects as in vertebrates.
However, lowering extra-cellular adenosine levels may have an
important function beyond the site of inflammation. Extra-cellular
adenosine is traditionally regarded as a local signal due to its usually
rapid metabolism; therefore only exerting localized effects on cells/
tissues surrounding its site of production. However, studies in the rat
model suggest it can act over longer distances in a hormone-like
manner [31]. In this rat model, lower-limb ischemia causes the
muscular accumulation of both extra-cellular adenosine and inosine
that upon reperfusion are rapidly released into the circulating blood.
It is these plasma nucleosides that then promote hepatic glucose
release and eventual hyperglycemia, via the activation of A3
adenosine receptor on hepatocytes. We recently demonstrated that
extra-cellular adenosine can also act as an anti-insulin hormone
stimulating a release of glucose from stores in the Drosophila model
[26]. Therefore a connection between the work presented here
(demonstrating the quite exclusive expression of ADGF-A in sites of
inflammation) and our previous study (showing the hyperglycemic
effect caused by the deficiency of ADGF-A associated with increased
extra-cellular adenosine [26]) could lead to a reappraisal of the roles
of extra-cellular adenosine and its regulation by ADGF-A/ADA2.
Accordingly, damaged tissues and sites of inflammation generating
significant amounts of extra-cellular adenosine, may serve as sites of
hormone production that alert an organism towards the appropriate
allocation of energy reserves towards mounting a necessary immune
reaction. Such a mechanism would need to be under tight control as
nottoprecipitateharmfulhyperglycemiaandeventuallyuncontrolled
loss of energy reserves. Therefore, once the stimulus for the
inflammation is under control, marked by the presence of sufficient
activated immune cells at the inflammation site, the signal for energy
release should be suppressed. This could explain why ADGF-A
protein is only expressed in fully adhered immune cells at site of
inflammationi.e., to dampen this important but potentiallydangerous
signal. The deficiency of ADGF-A protein that causes hyperglycemia
and progressive loss of energy reserves in flies [26] illustrates the
potential importance of this regulatory circuit. The ability of extra-
cellular adenosine to stimulate glucose release over longer distances
[31] and the expression of ADA2 in sites of inflammation [7,9]
suggest that similar roles of adenosine and ADA2 in energy allocation
could be applicable to mammalian systems.
To better understand the immunomodulatory roles of ATP and
adenosine it is important to monitor dynamic changes in the
expression of their receptors and the enzymes regulating their in
vivo concentrations. This is especially applicable in a time when
increasing attention is being paid to the role of adenosine system in
inflammation and its involvement in, for example, the pathophys-
iology of inflammatory bowel diseases [30]. Our work demon-
strates that Drosophila could serve as a valuable and convenient
model for visualization of such dynamic changes an in vivo
context.
Conclusions
Our work reports the creation of a functional in vivo expression
reporter for ADGF-A using precise gene replacement homologous
recombination procedures. Results of this work confirm the
expression of ADGF/ADA2 enzymes in the site of inflammation
by showing that ADGF-A expression occurs specifically in the
adhered immune cells of such sites in Drosophila. This supports
the view that the inflammatory response and its regulation are
evolutionary ancient and Drosophila and mammalian systems
share common mechanistic features. Our model also suggests that
the expression of adenosine deaminase during inflammation
response might be regulated at post-transcriptional level, therefore
potentially providing a means of rapid responding regulation. Our
previously uncharacterised observations of ADGF-A expression
highlight its potential regulatory role in energy allocation
stimulated by extra-cellular adenosine.
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